LIZHU Group (000513.SZ): Injection Alizapride Microspheres Obtains Registration Approval

China Fortune Finance and Economics App News, Liuzhu Group (000513.SZ) announced that recently, its wholly-owned subsidiary, Zhuhai Liuzhu Microspheres Technology Co., Ltd. (hereinafter referred to as "Liuzhu Microspheres"), has received the "Drug Registration Certificate" (Certificate Number: 2025S01188) issued by the National Medical Products Administration, and the injectable aliprazole microspheres have been approved for listing.